UPL gains 7% in four days on hopes of margin expansion

Brokerages CLSA and Emkay Global Financial Services have recommended 'buy' rating on UPL with target prices of Rs 1,100 and Rs 910, respectively.

agrochemical
Even after a 23 per cent rise in shares of the company over the past month, analysts maintain their positive stance and see further upside.
SI Reporter Mumbai
2 min read Last Updated : Jan 10 2022 | 11:27 AM IST
Shares of UPL were up 3.6 per cent at Rs 817.50 in Monday’s intra-day trade, quoting higher for the fourth straight trading day, and having rallied 7 per cent during the period on hopes of margin expansion. The market price of the company, a global leader of crop protection products and sustainable agricultural solutions, had hit a 52-week high of Rs 864.75 on June 8, 2021.

Brokerage firms CLSA and Emkay Global Financial Services have recommended ‘buy’ rating on UPL with target prices of Rs 1,100 and Rs 910, respectively.

UPL is aiming for a 25 per cent earnings before interest, taxes, depreciation, and amortization (ebitda) margin by FY26 vs 20.6 per cent in the first half (April-September) of the financial year 2021-22 (H1FY22).

Success in differentiated and sustainable products (management expects a 50 per cent contribution to sales from such products by FY26 from 29 per cent currently) and unique farmeroriented solutions that create demand for such products should enable UPL to achieve this goal. A transition towards high-value products should drive a PE rerating, CLSA said.

“We reiterate a BUY rating, raise our target price from Rs 1,060 to Rs 1,100, and raise FY22-24 EPS estimates 2-3 per cent as we build in spot currency assumptions,” the foreign brokerage said.

“Our Buy thesis is underpinned by 8 per cent FY22E-25E revenue CAGR, driven by 19 per cent CAGR in Differentiated and Sustainable (D&S) solutions; EBITDA margin expansion from 22.5 per cent in FY22E to 24.1 per cent in FY25E, supported by innovative products; around 18 per cent profit after tax (PAT) CAGR over FY22E-25E, supported by EBITDA margin expansion and lower interest outgo; and substantial net debt reduction from Rs 16,600 crore in FY22E to Rs 3,200 crore in FY25E from healthy cash flow generation,” said Emkay Global Financial Services.

Further, upside risk stems from the monetization of UPL’s fast-growing specialty chemicals business (Rs 45/ share, potentially) and nurture.farm initiative. Downside risks are adverse agronomical conditions in key markets, and adverse forex fluctuations, the brokerage firm added.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Buzzing stocksUPLMarketsstock markets

Next Story